Company Profile

SanBio Co. Ltd. (OTC: SNBOY)
6:09 PM UTC, 04/09/24
Last: $2.81 Change: -2.67 %Change: -48.72% Volume: 211
Detailed Quote
Open: $ 2.81   Volume: 211
High: $ 2.81   Yield(%) 0.00
Low: $ 2.81   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 448.15M
EPS ($) -0.23   Shares Out: 68.63M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 104.67
% Price Change (last 13 weeks): 131.77
% Price Change (last 26 weeks): 32.01
% Price Change (last 52 weeks): 53.12
% Price Change (year to date): 31.15
Management Effectiveness
Return on Equity (%): -70.10
Return on Assets (%): -42.01
Return on Invested Capital (%): -59.81
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
SanBio Co., Ltd. engages in the development, production and sale of regenerative cells medicines. It provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded on February 27, 2013 and is headquartered in Tokyo, Japan.
SanBio Co. Ltd.
St. Luke Tower, 32/F 8-1 Akaishi-cho Chuo-Ku
Tokyo TY 104-0044

Phone: 81.3.6264.3481
Fax: n/a
http://www.sanbio.com
Per Share Data
Earnings (1year) ($): -0.23
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.28
Cash Flow ($): -0.27
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 13.77
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 5.45
Current Ratio (x): 5.45
LT Debt/Equity (x): 14.22
Total Debt/Equity (x): 23.81



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.